Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Group A and Group C Meningococcal Polysaccharide Vaccine market was valued at US$ 293.3 million in 2022 and is projected to reach US$ 430.2 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Meningococcal disease, caused by Neisseria meningitidis, can cause serious illness and even death. The global burden of meningococcal disease, especially serogroups A and C, drives the need for effective vaccines to prevent these infections.
After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.
This report aims to provide a comprehensive presentation of the global market for Group A and Group C Meningococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Group A and Group C Meningococcal Polysaccharide Vaccine. This report contains market size and forecasts of Group A and Group C Meningococcal Polysaccharide Vaccine in global, including the following market information:
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Group A and Group C Meningococcal Polysaccharide Vaccine companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Group A and Group C Meningococcal Polysaccharide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Segment Percentages, by Type, 2022 (%)
Class 1 Vaccine
Class II Vaccine
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Group A and Group C Meningococcal Polysaccharide Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Group A and Group C Meningococcal Polysaccharide Vaccine revenues share in global market, 2022 (%)
Key companies Group A and Group C Meningococcal Polysaccharide Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Group A and Group C Meningococcal Polysaccharide Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Walvax
Lanzhou Institute of Biological Products
AIM Bio
Sanofi Pasteur
GSK
Hualan Bio
ZFSW
Changsheng
Kanghua Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Group A and Group C Meningococcal Polysaccharide Vaccine, market overview.
Chapter 2: Global Group A and Group C Meningococcal Polysaccharide Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Group A and Group C Meningococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Group A and Group C Meningococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Group A and Group C Meningococcal Polysaccharide Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Overall Market Size
2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size: 2022 VS 2029
2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Group A and Group C Meningococcal Polysaccharide Vaccine Players in Global Market
3.2 Top Global Group A and Group C Meningococcal Polysaccharide Vaccine Companies Ranked by Revenue
3.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Companies
3.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Companies
3.5 Global Group A and Group C Meningococcal Polysaccharide Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Group A and Group C Meningococcal Polysaccharide Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Group A and Group C Meningococcal Polysaccharide Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Group A and Group C Meningococcal Polysaccharide Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Group A and Group C Meningococcal Polysaccharide Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Markets, 2022 & 2029
4.1.2 Class 1 Vaccine
4.1.3 Class II Vaccine
4.2 By Type - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts
4.2.1 By Type - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales & Forecasts
4.3.1 By Type - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2018-2023
4.3.2 By Type - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2024-2029
4.3.3 By Type - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Group A and Group C Meningococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts
5.2.1 By Application - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales & Forecasts
5.3.1 By Application - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2018-2023
5.3.2 By Application - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2024-2029
5.3.3 By Application - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Group A and Group C Meningococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts
6.2.1 By Region - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales & Forecasts
6.3.1 By Region - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2018-2023
6.3.2 By Region - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2024-2029
6.3.3 By Region - Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2018-2029
6.4.3 US Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.4.4 Canada Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.4.5 Mexico Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2018-2029
6.5.3 Germany Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.4 France Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.5 U.K. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.6 Italy Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.7 Russia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.9 Benelux Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2018-2029
6.6.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.4 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.5 South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.7 India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2018-2029
6.7.3 Brazil Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.7.4 Argentina Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales, 2018-2029
6.8.3 Turkey Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8.4 Israel Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8.6 UAE Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Walvax
7.1.1 Walvax Company Summary
7.1.2 Walvax Business Overview
7.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Major Product Offerings
7.1.4 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Walvax Key News & Latest Developments
7.2 Lanzhou Institute of Biological Products
7.2.1 Lanzhou Institute of Biological Products Company Summary
7.2.2 Lanzhou Institute of Biological Products Business Overview
7.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Major Product Offerings
7.2.4 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Lanzhou Institute of Biological Products Key News & Latest Developments
7.3 AIM Bio
7.3.1 AIM Bio Company Summary
7.3.2 AIM Bio Business Overview
7.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Major Product Offerings
7.3.4 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 AIM Bio Key News & Latest Developments
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Company Summary
7.4.2 Sanofi Pasteur Business Overview
7.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Major Product Offerings
7.4.4 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Pasteur Key News & Latest Developments
7.5 GSK
7.5.1 GSK Company Summary
7.5.2 GSK Business Overview
7.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Major Product Offerings
7.5.4 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 GSK Key News & Latest Developments
7.6 Hualan Bio
7.6.1 Hualan Bio Company Summary
7.6.2 Hualan Bio Business Overview
7.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Major Product Offerings
7.6.4 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Hualan Bio Key News & Latest Developments
7.7 ZFSW
7.7.1 ZFSW Company Summary
7.7.2 ZFSW Business Overview
7.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Major Product Offerings
7.7.4 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 ZFSW Key News & Latest Developments
7.8 Changsheng
7.8.1 Changsheng Company Summary
7.8.2 Changsheng Business Overview
7.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Major Product Offerings
7.8.4 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Changsheng Key News & Latest Developments
7.9 Kanghua Bio
7.9.1 Kanghua Bio Company Summary
7.9.2 Kanghua Bio Business Overview
7.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Major Product Offerings
7.9.4 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Kanghua Bio Key News & Latest Developments
8 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Capacity, Analysis
8.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Capacity, 2018-2029
8.2 Group A and Group C Meningococcal Polysaccharide Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Group A and Group C Meningococcal Polysaccharide Vaccine Supply Chain Analysis
10.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Value Chain
10.2 Group A and Group C Meningococcal Polysaccharide Vaccine Upstream Market
10.3 Group A and Group C Meningococcal Polysaccharide Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Group A and Group C Meningococcal Polysaccharide Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
